US Broker Ratings

Cardinal Health, Inc. (CAH) Stock Analysis: Potential 20.82% Upside Amid Robust Revenue Growth

Cardinal Health, Inc. (NYSE: CAH), a prominent player in the healthcare sector, is capturing the attention of investors with its notable growth potential and strategic market..

Pfizer, Inc. (PFE) Stock Analysis: Dividend Yield of 6.36% Sparks Investor Curiosity

Pfizer Inc. (NYSE: PFE), a prominent player in the healthcare sector, stands as a formidable force within the drug manufacturing industry. With a market capitalization of..

Becton, Dickinson and Company (BDX) Stock Analysis: Exploring a 26.91% Potential Upside in the Healthcare Sector

Becton, Dickinson and Company (NYSE: BDX), a stalwart in the healthcare sector, continues to draw investor attention with its robust market presence and a promising growth..

Elevance Health, Inc. (ELV) Stock Analysis: A Look at Potential 33% Upside and Robust Revenue Growth

For investors navigating the ever-evolving landscape of healthcare stocks, Elevance Health, Inc. (NYSE: ELV) offers a compelling proposition with significant growth potential. With a market capitalization..

Vertex Pharmaceuticals (VRTX) Stock Analysis: Strong Buy Ratings and a 26% Upside Potential

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX), a stalwart in the biotechnology industry, stands out as a compelling investment opportunity. With a robust market capitalization of $110.01 billion,..

Danaher Corporation (DHR) Stock Analysis: A Healthcare Giant with 45.94% Potential Upside

Danaher Corporation (NYSE: DHR), a formidable player in the healthcare sector, is capturing investor attention with a significant potential upside of 45.94%. This diagnostics and research..

Novartis AG (NVS) Stock Analysis: Evaluating Growth Potential and Dividend Appeal

Novartis AG (NYSE: NVS), a global healthcare titan based in Basel, Switzerland, continues to captivate investor interest with its robust market presence and compelling financial metrics...

Cencora, Inc. (COR) Stock Analysis: Exploring a 30% Upside Potential in the Healthcare Sector

Cencora, Inc. (NYSE: COR), a stalwart in the healthcare sector through its medical distribution operations, is capturing investor attention with a compelling potential upside of 30.55%...

Standard BioTools Inc. (LAB) Stock Analysis: Is a 61.80% Upside Within Reach for This Medical Device Innovator?

Standard BioTools Inc. (NASDAQ: LAB), a key player in the healthcare sector specializing in medical devices, presents a compelling investment opportunity with its potential for a..

Cross Country Healthcare, Inc. (CCRN) Stock Analysis: Navigating the Healthcare Staffing Landscape with a 19.90% Potential Upside

Cross Country Healthcare, Inc. (NASDAQ: CCRN) stands out as a key player in the healthcare sector, specifically within the medical care facilities industry. With a market..

AtaiBeckley Inc. (ATAI) Stock Analysis: Why Analysts Are Bullish With a 280% Potential Upside

AtaiBeckley Inc. (NASDAQ: ATAI), a clinical-stage biopharmaceutical company focused on innovative treatments for mental health disorders, is capturing significant attention from investors and analysts alike. Operating..

Celcuity Inc. (CELC) Stock Analysis: Biotech Innovator with a 9.4% Upside Potential

Celcuity Inc. (NASDAQ: CELC), a clinical-stage biotechnology company, is turning heads in the healthcare sector with its innovative approach to cancer treatment. Based in Minneapolis, Minnesota,..

Tilray Brands, Inc. (TLRY) Stock Analysis: Unpacking a Potential 79% Upside Opportunity

Tilray Brands, Inc. (NASDAQ: TLRY), a prominent name in the healthcare sector under the specialty and generic drug manufacturers industry, presents an intriguing opportunity for investors..

SIGA Technologies Inc. (SIGA) Stock Analysis: Navigating Revenue Challenges While Eyeing Future Potential

SIGA Technologies Inc. (NASDAQ: SIGA), a company at the forefront of the health security market with its leading antiviral product TPOXX, presents a mixed bag for..

AngioDynamics, Inc. (ANGO) Investor Outlook: Unpacking a 71.55% Potential Upside

AngioDynamics, Inc. (NASDAQ: ANGO), a leader in the healthcare sector specializing in medical instruments and supplies, is catching the attention of investors with a noteworthy potential..

Sana Biotechnology, Inc. (SANA) Stock Analysis: Exploring a Potential 178% Upside in the Biotech Sector

Sana Biotechnology, Inc. (NASDAQ: SANA) presents an intriguing opportunity for investors looking to tap into the burgeoning field of engineered cell therapies. Operating in the healthcare..

Tectonic Therapeutic, Inc. (TECX) Stock Analysis: Unveiling a Potential 154% Upside for Investors

Tectonic Therapeutic, Inc. (NASDAQ: TECX) is capturing the attention of investors with its promising biotechnology innovations and an impressive potential upside of 154.39% according to analyst..

Oric Pharmaceuticals, Inc. (ORIC) Stock Analysis: 71% Upside Potential Ignites Investor Interest

Oric Pharmaceuticals, Inc. (NASDAQ: ORIC), a dynamic player in the biotech sector, is capturing the attention of investors with its promising therapeutic developments aimed at countering..

REGENXBIO Inc. (RGNX) Investor Outlook: A Biotech Stock with a Potential 236% Upside

REGENXBIO Inc. (NASDAQ: RGNX), a notable player in the biotechnology sector, is catching the eyes of investors with a staggering potential upside of 236.78%. Despite the..

Auna SA (AUNA)

⚠️ No article content returned.

..
Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds